Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies

被引：0
|
作者：
Krauter, Juergen [1 ]
Heil, Gerhard [2 ]
Hoelzer, Dieter [3 ]
Martin, Hans [3 ]
Ottmann, Oliver G. [3 ]
Finke, Juergen [4 ]
Luebbert, Michael [5 ]
Heit, Wolfgang [6 ]
Fiedler, Walter [7 ]
Kanz, Lothar [8 ]
Schlimok, Guenter [9 ]
Kirchner, Hartmut [10 ]
Raghavachar, Aruna [11 ]
Brugger, Wolfram [12 ]
Doehner, Hartmut [13 ]
Ganser, Arnold [1 ]
机构：
[1] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, D-3000 Hannover, Germany
[2] Krankenhaus Ludenscheid, Ludenscheid, Germany
[3] JW Goethe Univ Hosp, Frankfurt, Germany
[4] Univ Med Ctr Freiburg, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, D-7800 Freiburg, Germany
[6] Kliniken Essen Sud, Essen, Germany
[7] Univ Hosp Eppendorf, Dept Hematol & Oncol, Hamburg, Germany
[8] Univ Tubingen, Tubingen, Germany
[9] Klinikum Augsburg, Med Klin 2, Augsburg, Germany
[10] Klinik Hannover, Hannover, Germany
[11] HELIOS Klinikum Wuppertal, Med Klin 1, Wuppertal, Germany
[12] Hosp Villingen Schwenningen, Schwenningen, Germany
[13] Univ Ulm, Ulm, Germany
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [41] Is iron-overload an independent prognostic factor in AML and MDS patients undergoing allogeneic stem cell transplantation?
    Wermke, M.
    Schmidt, A.
    Middeke, M.
    Sockel, K.
    von Bonin, M.
    Schoenefeldt, C.
    Plodeck, V
    Laniado, M.
    Schetelig, J.
    Ehninger, G.
    Bornhaeuser, M.
    Platzbecker, U.
    ONKOLOGIE, 2012, 35 : 200 - 200
  • [42] Survival of Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Patients Receiving Stem Cell Transplantation (SCT)
    Nath, Rajneesh
    Reddy, Vijay
    Kapur, Anil
    Gebregergish, Samron
    Gurskyte, Laura
    Kulakova, Margarita
    Heeg, Bart
    Berger, Mark S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [43] NON-INTENSIVE TARGET THERAPY IN RELAPSED AND REFRACTORY AML: A BRIDGE TO ALLOGENEIC STEM CELL TRANSPLANTATION
    Budaeva, I.
    Shatilova, A.
    Motorin, D.
    Badaev, R.
    Siordiya, N.
    Ivanov, V.
    Bogdanov, K.
    Mirolyubova, Y.
    Nikulina, T.
    Alekseeva, Y.
    Lomaia, E.
    Girshova, L.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S51 - S52
  • [44] Prognostic factors for allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Wong, R
    Shahjahan, M
    De Lima, M
    Anagnostopoulos, A
    Estey, E
    Champlin, R
    Andersson, B
    Khouri, I
    Giralt, S
    BLOOD, 2002, 100 (11) : 853A - 853A
  • [45] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Evgenii Shumilov
    Inna Shakhanova
    Johanna Flach
    Nicole Schmidt
    Susanne Buerki
    Myriam Legros
    Marie-Noëlle Kronig
    Yishai Ofran
    Sabine Gerull
    Michael Medinger
    Behrouz Mansouri Taleghani
    Jakob Passweg
    Jörg Halter
    Ulrike Bacher
    Thomas Pabst
    Bone Marrow Transplantation, 2022, 57 : 224 - 231
  • [46] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Shumilov, Evgenii
    Shakhanova, Inna
    Flach, Johanna
    Schmidt, Nicole
    Buerki, Susanne
    Legros, Myriam
    Kronig, Marie-Noelle
    Ofran, Yishai
    Gerull, Sabine
    Medinger, Michael
    Taleghani, Behrouz Mansouri
    Passweg, Jakob
    Halter, Joerg
    Bacher, Ulrike
    Pabst, Thomas
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 224 - 231
  • [47] Early Versus Late Allogeneic Hematopoietic Cell Transplantation in Patients with AML - Results From the Randomized AML 2003 Trial
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Schaich, Markus
    Roellig, Christoph
    Schaefer-Eckart, Kerstin
    Haenel, Mathias
    Einsele, Hermann
    Schmitz, Norbert
    Roesler, Wolf
    Mayer, Jiri
    Ho, Anthony D.
    Aulitzky, Walter E.
    Kramer, Michael
    Platzbecker, Uwe
    Serve, Hubert
    Stelljes, Matthias
    Reichle, Albrecht
    Baldus, Claudia D.
    Berdel, Wolfgang E.
    Thiede, Christian
    Schetelig, Johannes
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S224 - S224
  • [48] Next-generation sequencing to identify mutations that may predict outcome after allogeneic stem cell transplantation for AML.
    Luskin, Marlise Rachael
    Carroll, Martin
    Morrissette, Jennifer J.
    Daber, Robert D.
    Frey, Noelle V.
    Loren, Alison W.
    Hexner, Elizabeth O.
    Mangan, James K.
    Perl, Alexander E.
    Sloan, Caroline E.
    Stadtmauer, Edward Allen
    Bagg, Adam
    Luger, Selina M.
    Porter, David L.
    Reshef, Ran
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] DNMT3A mutation in AML patients after allogeneic stem cell transplantation
    Blau, O.
    Berenstein, R.
    Nogai, A.
    Rieger, K.
    Hemmati, P.
    Jehn, C.
    Doerken, B.
    Arnold, R.
    Blau, I. W.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S60 - S60
  • [50] OUTCOME OF PATIENTS WITH IDH-MUTATED AML FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
    Schroeder, Thomas
    Flossdorf, Sarah
    Pabst, Caroline
    Stadler, Michael
    Schetelig, Johannes
    Wehr, Claudia
    Schuh, Claudia
    Stelljes, Matthias
    Sala, Elisa
    Burchert, Andreas
    Kaivers, Jennifer
    Reinhardt, Christian
    Kroeger, Nicolaus
    Fleischhauer, Katharina
    Rautenberg, Christina
    BONE MARROW TRANSPLANTATION, 2024, 59 : 145 - 146
12345